Korea neglects R&D for new drugs
Published: 2009-08-24 06:58:00
Updated: 2009-08-24 06:58:00
Korea is not investing enough in research and development (R&D) projects for new drugs, a report showed recently. This partly explains why Korea is lagging behind others in the pharmaceutical industry, the report said.
According to the Korea Drug Research Association (KDRA), merely 10 percent...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
